Genomic & Biopharma NewsHarnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals. For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
|ORB Company Blog, 2017-03-31 21:41:45|
Obesity causes poorer cardiovascular health in young adults
Copenhagen, Denmark: Higher than normal body mass index (BMI) is known to lead to cardiovascular ill-health in mid-to-late life, but there has been limited investigation of its effect in young, apparently healthy, adults.
|News Medical Life Sciences, 2017-05-27 23:24:00|
FDA issues Complete Response Letter for Sunovion’s New Drug Application to treat COPD patients
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application for SUN-101/eFlow (glycopyrrolate) for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
|News Medical Life Sciences, 2017-05-27 23:19:00|
American Red Cross offers 15 safety tips for summer season
Memorial Day weekend marks the unofficial start to summer with warm weather and summer fun in the sun just ahead.
|News Medical Life Sciences, 2017-05-27 23:14:00|
Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
|ORB Company News, 2016-12-28 18:58:47|
World’s first Percutaneous Injectable Anchor System receives CE Mark approval
Freedom Neuro BV, a medical device distributor for Stimwave Technologies Incorporated, today announced CE Mark approval for the world's first Percutaneous Injectable Anchor System.
|News Medical Life Sciences, 2017-05-27 23:07:00|
Researchers can attack cancer by working together, says UNC Charlotte professor
MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.
|News Medical Life Sciences, 2017-05-27 23:02:00|
Molina Healthcare, a top Obamacare insurer, investigates breach of patients’ data
Molina Healthcare, a major insurer in Medicaid and state exchanges across the country, has shut down its online patient portal as it investigates a potential data breach that may have exposed sensitive medical information.
|News Medical Life Sciences, 2017-05-27 12:54:53|
Dragon Master Foundation to fund DIPG trial that will make patient data available live in the cloud
Dragon Master Foundation has announced plans to provide $300,000 in funding for the first clinical trial that will make patient data available live in the cloud while the trial is underway.
|News Medical Life Sciences, 2017-05-27 12:52:44|
Preventative measures can help minimize rising threat of tick-borne illnesses
Healthcare providers and researchers agree: this will be a bad year for ticks and we need use preventative measures to minimize the threat of tick-borne illnesses.
|News Medical Life Sciences, 2017-05-27 09:34:15|
FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC
Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.
|News Medical Life Sciences, 2017-05-27 09:18:59|